ATE441859T1 - Verfahren zur diagnose der immunität wiederkehrenden spontanen schwangerschaftsabbruchs sowie verfahren zur behandlung und überwachung - Google Patents
Verfahren zur diagnose der immunität wiederkehrenden spontanen schwangerschaftsabbruchs sowie verfahren zur behandlung und überwachungInfo
- Publication number
- ATE441859T1 ATE441859T1 AT04712989T AT04712989T ATE441859T1 AT E441859 T1 ATE441859 T1 AT E441859T1 AT 04712989 T AT04712989 T AT 04712989T AT 04712989 T AT04712989 T AT 04712989T AT E441859 T1 ATE441859 T1 AT E441859T1
- Authority
- AT
- Austria
- Prior art keywords
- recurrent spontaneous
- monitoring
- level
- treatment
- present
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 5
- 230000000306 recurrent effect Effects 0.000 title abstract 4
- 238000012544 monitoring process Methods 0.000 title abstract 2
- 238000010521 absorption reaction Methods 0.000 title 1
- 230000036039 immunity Effects 0.000 title 1
- 230000002269 spontaneous effect Effects 0.000 title 1
- 206010000234 Abortion spontaneous Diseases 0.000 abstract 3
- 230000003460 anti-nuclear Effects 0.000 abstract 3
- 230000001900 immune effect Effects 0.000 abstract 3
- 208000000995 spontaneous abortion Diseases 0.000 abstract 3
- 210000001124 body fluid Anatomy 0.000 abstract 2
- 239000010839 body fluid Substances 0.000 abstract 2
- 238000009007 Diagnostic Kit Methods 0.000 abstract 1
- 102000016359 Fibronectins Human genes 0.000 abstract 1
- 108010067306 Fibronectins Proteins 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 210000000349 chromosome Anatomy 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6875—Nucleoproteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/36—Gynecology or obstetrics
- G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Reproductive Health (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Electrotherapy Devices (AREA)
- Automatic Analysis And Handling Materials Therefor (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/CN2004/000134 WO2005080980A1 (fr) | 2004-02-20 | 2004-02-20 | Procede pour diagnostiquer un avortement spontane recurrent immunitaire et procede de traitement et de suivi |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE441859T1 true ATE441859T1 (de) | 2009-09-15 |
Family
ID=34876877
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04712989T ATE441859T1 (de) | 2004-02-20 | 2004-02-20 | Verfahren zur diagnose der immunität wiederkehrenden spontanen schwangerschaftsabbruchs sowie verfahren zur behandlung und überwachung |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US7674590B2 (de) |
| EP (1) | EP1722225B1 (de) |
| CN (1) | CN100504388C (de) |
| AT (1) | ATE441859T1 (de) |
| DE (1) | DE602004022995D1 (de) |
| WO (1) | WO2005080980A1 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101407843B (zh) * | 2008-11-19 | 2011-03-09 | 南方医科大学 | 一种检测导致自然流产的染色体数目异常的试剂盒 |
| EP2545376A4 (de) | 2010-03-11 | 2013-08-28 | Univ Louisville Res Found | Verfahren zur vorhersage und senkung des risikos von schwangerschaftsverlusten |
| CN111254111A (zh) * | 2020-02-29 | 2020-06-09 | 贵州医科大学 | 靶向治疗习惯性流产和免疫性不孕的细胞及其制备方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2836362A1 (de) * | 1978-08-19 | 1980-03-06 | Behringwerke Ag | Diagnostisches mittel |
| US4444879A (en) * | 1981-01-29 | 1984-04-24 | Science Research Center, Inc. | Immunoassay with article having support film and immunological counterpart of analyte |
| WO1983000877A1 (en) * | 1981-08-31 | 1983-03-17 | Icl Scient | Glucose oxidase immunohistochemical detection of antinuclear antibodies |
| US5281522A (en) * | 1988-09-15 | 1994-01-25 | Adeza Biomedical Corporation | Reagents and kits for determination of fetal fibronectin in a vaginal sample |
| WO1993009432A1 (en) * | 1991-11-04 | 1993-05-13 | Adeza Biomedical Corporation | Screening method for identifying women at increased risk for imminent delivery |
| CN1102097A (zh) * | 1993-10-29 | 1995-05-03 | 泰安市中医医院 | 人早期胚胎因子及其制取法和在制药中的应用 |
| JPH09218202A (ja) * | 1995-12-08 | 1997-08-19 | B M L:Kk | 抗核抗体の検出方法及び検出用キット |
| US7029867B2 (en) * | 2000-11-22 | 2006-04-18 | Eiji Matsuura | Method of assaying antilaminin-1 antibody and application thereof |
| CN1171612C (zh) * | 2002-04-02 | 2004-10-20 | 复旦大学附属妇产科医院 | 一种治疗自然流产的中药复方制剂及其制备方法 |
| WO2005079814A1 (fr) * | 2004-02-20 | 2005-09-01 | Beijing Xinjing Antai Medical And Technology Service Limited Corp. | Composition pharmaceutique utilisee pour le traitement de l'avortement spontane recurrent et procede associe |
-
2004
- 2004-02-20 US US10/586,285 patent/US7674590B2/en not_active Expired - Lifetime
- 2004-02-20 AT AT04712989T patent/ATE441859T1/de not_active IP Right Cessation
- 2004-02-20 WO PCT/CN2004/000134 patent/WO2005080980A1/zh not_active Ceased
- 2004-02-20 EP EP04712989A patent/EP1722225B1/de not_active Expired - Lifetime
- 2004-02-20 DE DE602004022995T patent/DE602004022995D1/de not_active Expired - Lifetime
- 2004-02-20 CN CNB2004800299198A patent/CN100504388C/zh not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DE602004022995D1 (de) | 2009-10-15 |
| CN1867829A (zh) | 2006-11-22 |
| US20070160997A1 (en) | 2007-07-12 |
| US7674590B2 (en) | 2010-03-09 |
| EP1722225B1 (de) | 2009-09-02 |
| CN100504388C (zh) | 2009-06-24 |
| EP1722225A1 (de) | 2006-11-15 |
| WO2005080980A1 (fr) | 2005-09-01 |
| EP1722225A4 (de) | 2007-07-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE423217T1 (de) | Assays zur überwachung von krebspatienten auf grundlage der spiegel von analytenkomponenten des plasminogen-aktivator-systems in proben von körperflüssigkeiten | |
| ATE533061T1 (de) | Verfahren zur diagnose bakterieller infektionen | |
| WO2004046729A3 (en) | Bodily fluid markers of tissue hypoxia | |
| WO2005029091A3 (en) | Method of using cytokine assays to diagnose, treat, and evaluate inflammatory and autoimmune diseases | |
| ATE386942T1 (de) | Verfahren zur voraussage, zur diagnose und zur vergleichenden diagnose von alzheimer | |
| DK1421215T3 (da) | Fremgangsmåder til evaluering af patologiske tilstande under anvendelse af ekstracellulært RNA | |
| ATE223051T1 (de) | Verfahren zur diagnose gutartiger prostataerkrankungen | |
| DE602006014535D1 (de) | Verwendung von nt-proanp und nt-probnp zur diagnose von herzerkrankungen | |
| ATE451475T1 (de) | Verfahren und systeme zur diagnose von nicht das zentrale nervensystem (zns) betreffenden krankheiten in zns-proben | |
| NO20050186L (no) | Oligosakkaridbiomarkorer for mucopolysakkaridoser og andre beslektede forstyrrelser | |
| SG171691A1 (en) | Biomarkers for diagnosing multiple sclerosis, and methods thereof | |
| ATE385574T1 (de) | Verfahren zur diagnose von juvenilen idiopathischen skoliosen und verwandten erkrankungen | |
| AU2003259222A1 (en) | Method of diagnosing alzheimer's disease | |
| WO2005098433A3 (en) | Diagnostic assays for alzheimer’s disease | |
| ATE514948T1 (de) | In vitro verfahren zur diagnose von neurodegenerativen erkrankungen | |
| ATE441859T1 (de) | Verfahren zur diagnose der immunität wiederkehrenden spontanen schwangerschaftsabbruchs sowie verfahren zur behandlung und überwachung | |
| DE502006008028D1 (de) | Liquordiagnostisches in vitro verfahren zur diagnose von demenz-erkrankungen und neuroinflammatorischen erkrankungen | |
| ATE465408T1 (de) | Verfahren zur diagnose und überwachung von neurologischen erkrankungen durch nachweis eines encephalotoxins | |
| DE50313393D1 (de) | Verfahren zur diagnose von entzündungserkrankungen und infektionen mittels bestimmung von lasp-1/ lap-1 | |
| WO2007015113A3 (en) | New protein isoforms of the pif-family and uses thereof | |
| JP2009506301A5 (de) | ||
| WO2006067792A3 (en) | Aldolase autoantigens useful in diagnosis and treatment of alzheimer's disease | |
| ATE406579T1 (de) | Verfahren zur diagnose von tumoren | |
| WO2022241292A3 (en) | Use of markers in the diagnosis and treatment of parkinson's disease | |
| DE60326269D1 (de) | Verfahren zur detektion von prpsc unter verwendung von gruppe ii aminoglykosid antibiotika |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |